FDA Opens a Pilot Program to Scrutinize Certain Laboratory Developed Tests, But Will It Generate Sufficient Interest? | Mintz

The U.S. Food and Drug Administration (FDA) announced a new pilot program on June 21, 2023 that gives sponsors of oncology products the opportunity to submit validation and performance...

Related Keywords

,Office Of Management ,Pilot Program ,Drug Administration ,Verifying Accurate Leading Edge ,Oncology Drug Products Used ,Certain In Vitro Diagnostic Tests ,